2021
DOI: 10.1164/rccm.202101-0055oc
|View full text |Cite
|
Sign up to set email alerts
|

Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 52 publications
0
17
0
Order By: Relevance
“…For example, detailed physiological studies in which the key OSA endotypes have been quantified and non-CPAP interventions delivered to improve one or more of the non-anatomical treatable traits can reduce OSA severity (Eckert et al, 2011;Edwards et al, 2012Edwards et al, , 2016bSands et al, 2018a;Aishah and Eckert, 2019;Taranto-Montemurro et al, 2019;Op de Beeck et al, 2021). Identification of patients with a low respiratory arousal threshold endotype may be an important physiological predictor of CPAP treatment failure (Gray et al, 2017;Zinchuk et al, 2021) and the presence of a low arousal threshold endotype is associated with mortality (Butler et al, 2019). Similarly, identification of patients impairment in endotypes such as high loop gain and highly collapsible pharyngeal airways may be important predictors for non-CPAP treatment failure including upper airway surgery, mandibular advancement splint therapy, hypoglossal nerve stimulation, pharmacotherapy (Edwards et al, 2016a;Li et al, 2017;Aishah and Eckert, 2019;Op de Beeck et al, 2021) and potentially positional therapy (Eckert, 2018b).…”
Section: Osa Endotypesmentioning
confidence: 99%
“…For example, detailed physiological studies in which the key OSA endotypes have been quantified and non-CPAP interventions delivered to improve one or more of the non-anatomical treatable traits can reduce OSA severity (Eckert et al, 2011;Edwards et al, 2012Edwards et al, , 2016bSands et al, 2018a;Aishah and Eckert, 2019;Taranto-Montemurro et al, 2019;Op de Beeck et al, 2021). Identification of patients with a low respiratory arousal threshold endotype may be an important physiological predictor of CPAP treatment failure (Gray et al, 2017;Zinchuk et al, 2021) and the presence of a low arousal threshold endotype is associated with mortality (Butler et al, 2019). Similarly, identification of patients impairment in endotypes such as high loop gain and highly collapsible pharyngeal airways may be important predictors for non-CPAP treatment failure including upper airway surgery, mandibular advancement splint therapy, hypoglossal nerve stimulation, pharmacotherapy (Edwards et al, 2016a;Li et al, 2017;Aishah and Eckert, 2019;Op de Beeck et al, 2021) and potentially positional therapy (Eckert, 2018b).…”
Section: Osa Endotypesmentioning
confidence: 99%
“…Additionally, both high and low pharyngeal muscle compensation are linked to poor CPAP adherence. Therefore, identifying patients who are likely to benefit from genioglossus muscle strengthening, and future studies on more efficient genioglossus muscle strengthening protocols, might help the CPAP adherence in OSA patients [27].…”
Section: Discussionmentioning
confidence: 99%
“…In this issue of the Journal , Zinchuk and colleagues (pp. 703–712 ) present important findings that overcome these limitations and underscore the importance of physiologic traits in predicting PAP adherence ( 12 ). Greater understanding in this area may inform novel approaches to improve the effectiveness of PAP therapy.…”
mentioning
confidence: 99%
“…Indeed, a recent post hoc analysis of a randomized trial of eszopiclone suggests that those with a low arousal threshold who use PAP >1 month may derive more benefit from the hypnotic than those with a high arousal threshold ( 9 ). Several existing therapies such as acetazolamide and supplemental oxygen also have efficacy in alleviating loop gain ( 14 ), which Zinchuk and colleagues found may be a barrier in longer-term adherence ( 12 ). An underexplored approach is customizing PAP technology and settings to harmonize with physiologic traits.…”
mentioning
confidence: 99%
See 1 more Smart Citation